Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2009
09/22/2009CA2503767C Pyridopyrrolizine and pyridoindolizine derivatives
09/22/2009CA2333086C Cocaine receptor binding ligands
09/22/2009CA2145407C New reagents for peptide couplings
09/17/2009WO2009114575A1 Tricyclic spiro pyrimidine derivatives as histamine h4 ligand
09/17/2009WO2009112845A1 Amido-thiophene compounds and their use
09/17/2009WO2009112832A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
09/17/2009WO2009112679A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
09/17/2009WO2009112678A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
09/17/2009WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
09/17/2009WO2009112652A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
09/17/2009WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics
09/17/2009WO2009112524A1 Pyridopyrimidines as plk1 ( polo-like kinase) inhibitors
09/17/2009WO2009112475A1 Pyrrolo [2, 3-b] pyridin derivatives as ikk2 inhibitors
09/17/2009WO2009112473A1 Novel compounds
09/17/2009WO2009112460A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors
09/17/2009WO2009112439A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors
09/17/2009WO2009112139A1 Azaindole compounds for treatment of central nervous system disorders
09/17/2009WO2009111943A1 The compounds as the estrogen related receptors modulators and the uses thereof
09/17/2009WO2009089263A3 Novel compositions and methods of use
09/17/2009WO2007129195A3 4-pyrimidine-5-amino-pyrazole compounds
09/17/2009US20090234124 Polyetheramine production method
09/17/2009US20090233960 Kinase Inhibitors
09/17/2009US20090233956 NOVEL PYRROLO(2,3-b) PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS
09/17/2009US20090233955 1H-Pyrrolo[2,3-B]Pyridnes
09/17/2009US20090233945 New compounds 834
09/17/2009US20090233936 Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes
09/17/2009US20090233923 Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof
09/17/2009US20090233907 Pyridopyrimidine Derivatives and Their Use as PDE4 Inhibitors
09/17/2009US20090233902 Indolopyridines as eg5 kinesin modulators
09/17/2009US20090233289 Novel DNA threading intercalators
09/17/2009US20090232844 Immunopotentiating compounds
09/17/2009US20090230857 Aromatic heterocyclic compound, organic light emitting diode comprising organic layer comprising the same and method of manufacturing the organic light emitting diode
09/17/2009US20090230849 Compound having oxadiazole ring structure bonded with aromatic heterocyclic ring and organic electroluminescent device
09/17/2009DE102008014028A1 Preparing imidazolium salts, preferably 1,3-disubstiuted imidazolium salts, useful e.g. as precursors of N-heterocyclic carbenes, comprises reducing 1,3-disubstituted-2-alkoxyimidazolium salts with hydrides and/or hydride donors
09/17/2009CA2750859A1 The compounds as the estrogen related receptors modulators and the uses thereof
09/17/2009CA2718194A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors
09/17/2009CA2718138A1 Azaindole compounds for treatment of central nervous system disorders
09/17/2009CA2716918A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
09/17/2009CA2716679A1 Amido-thiophene compounds and their use
09/17/2009CA2716079A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors
09/17/2009CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
09/17/2009CA2712629A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
09/17/2009CA2712609A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
09/17/2009CA2710801A1 2-benzoyl-imidazo(1,2-.alpha) pyridine derivatives, their preparation and their therapeutic application
09/17/2009CA2710797A1 Imidazo[1,2-.alpha.]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics
09/16/2009EP2101365A1 Organic electroluminescent device, display and illuminating device
09/16/2009EP2100894A1 Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
09/16/2009EP2099799A1 Spiro-piperidine derivatives
09/16/2009EP2099798A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
09/16/2009EP2099797A2 Compounds and compositions as protein kinase inhibitors
09/16/2009EP2099796A1 Aza-indolyl compounds and methods of use
09/16/2009EP2099787A1 Aminopyrimidines useful as inhibitors of protein kinases
09/16/2009EP2099770A2 Pyridazinones and furan-containing compounds
09/16/2009EP1999110B1 PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES
09/16/2009EP1828184B1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
09/16/2009EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
09/16/2009EP1478364B1 Selective antibacterial agents
09/16/2009EP1363629B1 Kappa opioid receptor ligands
09/16/2009CN101535310A Polymorphs of nicotinic intermediates
09/16/2009CN101535309A Novel compounds with affinity for amyloid
09/16/2009CN101535308A Substituted 6-phenyl-pyrido [2,3-D] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same
09/16/2009CN101535307A Triazole derivatives as kinase inhibitors
09/16/2009CN101531683A Bipyridine ruthenium/osmium ECL marker with phenothiazine power supplying groups in molecules
09/16/2009CN101531659A Calycanthine reference substance preparation method
09/16/2009CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/16/2009CN100540538C Large conductance calcium-activated k channel opener
09/15/2009US7589207 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide
09/15/2009US7589206 1-[4-(3-Chloro-phenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-piperidin-1-yl-methanone; analgesic; treats diseases caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor
09/15/2009US7589204 Indane compounds as CCR5 antagonists
09/15/2009US7589202 Substituted pyrazoles
09/15/2009US7589103 Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators
09/15/2009US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/15/2009US7589101 Compounds and compositions as protein kinase inhibitors
09/15/2009US7588113 Wheel drive
09/15/2009CA2376835C Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
09/15/2009CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole]
09/11/2009WO2009111550A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloal kanes
09/11/2009WO2009111337A1 Compounds and compositions as tlr activity modulators
09/11/2009WO2009111279A1 Pyrazole [3, 4-b] pyridine raf inhibitors
09/11/2009WO2009111277A1 Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
09/11/2009WO2009110542A1 Anilide compound and use thereof
09/11/2009WO2009110520A1 Heterocyclic compound
09/11/2009WO2009109987A2 Fused pyrimidine derivatives as trpv3 modulators
09/11/2009WO2009109782A2 Polycyclic organic compounds, retardation layer and compensation panel on their base
09/11/2009WO2009109651A1 SALTS OF A PYRAZINO[2,3-h][3]BENZAZEPINE DERIVATIVE
09/11/2009WO2009109620A1 Process for preparing enantiomerically pure indolopyridines
09/11/2009WO2009109517A1 Novel 3,8-diaza-bicyclo[3.2.1]octane- and 3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/11/2009WO2009109496A1 Process for the purification of sophora alkaloids
09/11/2009WO2009109341A1 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/11/2009WO2009109071A1 Imidazopyridine compounds
09/11/2009WO2009087151A9 Polymorphic forms of moxifloxacin hydrochloride and processes for preparation thereof
09/11/2009WO2009080721A3 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists
09/11/2009WO2009037570A3 Pyridine derivatives and methods of use thereof
09/11/2009WO2009026446A3 Hdac inhibitors
09/11/2009WO2009015067A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/11/2009CA2724008A1 Fused pyrimidine derivatives as trpv3 modulators
09/11/2009CA2717381A1 Process for preparing enantiomerically pure indolopyridines
09/11/2009CA2716952A1 Pyrazole [3,4-b] pyridine raf inhibitors
09/11/2009CA2716951A1 Raf inhibitor compounds and methods of use thereof
09/11/2009CA2716947A1 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors